Log In
BCIQ
Print this Print this
 

Bio-T-Gel, testosterone

  Manage Alerts
Collapse Summary General Information
Company ANI Pharmaceuticals Inc.
DescriptionTransdermal testosterone gel
Molecular Target Androgen receptor
Mechanism of ActionAndrogen receptor agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationHypogonadism
Indication DetailsTreat hypogonadism in men
Regulatory Designation
PartnerTeva Pharmaceutical Industries Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$40.0M

0

$40.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

06/24/2013

$40.0M

0

$40.0M

Get a free BioCentury trial today